Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock ... ( PHOENIX Feb. 13 /- Matrixx Initia...)

Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference

Date:2/13/2008

PHOENIX, Feb. 13 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," will be presenting on Wednesday February 20, 2008, at the Roth Capital Partners 20th Annual OC Growth Stock Conference.

The Company will be presenting at 11:30 a.m. PT. To listen to the live presentation please visit http://www.matrixxinc.com. Interested parties should login 15 minutes prior to the event to register and to install Windows Media Player if necessary. A replay of the presentation will be archived at the same web site address for 30 days.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) and Nasal Comfort(TM) products in the cough and cold category. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Cold Remedy
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
2. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
3. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
4. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
7. A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at Autism Through the Lifespan Conference February 14-17 in Orlando
8. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
9. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
10. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
11. Pet DRx to Present at Roth 20th Annual OC Growth Stock Conference

Post Your Comments:

Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock ...( PHOENIX Feb. 13 /- Matrixx Initia...),Health